Melatonin

Specifications

73-31-4CAS Number

200-797-7EC Number

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamideIUPAC Name

C13H16N2O2Chemical Formula

232.28 g/molMolecular Weight

Melatonin; 73-31-4; Melatonine; N-Acetyl-5-methoxytryptamine; N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide; Circadin; 5-Methoxy-N-acetyltryptamine; Melatol; N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; Melovine; Melapure; Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-; N-[2-(5-methoxyindol-3-yl)ethyl]acetamide; DTXSID1022421; N-acetyl-5-methoxy-tryptamine; N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide; NSC 113928; Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-; JL5DK93RCL; Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-; NSC-56423; 5-methoxy n-acetyl-tryptamine; NSC-113928; J5.258B; BCI-049; NSC113928; Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-; DTXCID002421; CHEBI:16796; NSC56423; N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; somease; Heidadouppi; Melaxen; Travelag; Vytalonin; Icenia; Vespro; General nutrit; Natures bounty; Quality health; Health aid; Amerix Melatonin; Life ext; Nature's blend; Safrel Melatonin; S.gard; Melatonin Phenolic; Melatonin 1527; Therapeutic Melatonin; MELATONIN CORD; RefChem:5990; MAX Sleep Junior Childrens SLEEP AID; 200-797-7; NSC-302012; Regulin; 8041-44-9; MFCD00005655; 3-(n-acetyl-2-aminoethyl)-5-methoxyindole; CHEMBL45; Melatonex; 3-N-Acetyl-5-methoxyl tryptamine; Melatonin (JAN); CAS-73-31-4; NCGC00015680-11; MELATONIN [JAN]; S1204; M02088; Posidorm; Primex; WLN: T56 BMJ D2MV1 GO1; [3H]melatonin; Melatonina (TN); [3H]-melatonin; ML1; SMR000326666; CCRIS 3472; N-(2-(5-methoxyindol-3-yl)ethyl)-Acetamide; N-[2-(5-methoxyindol-3-yl)ethyl]-Acetamide; SR-01000075559; EINECS 200-797-7; UNII-JL5DK93RCL; BRN 0205542; [3H]MLT; Melatonine?; Guna-dermo; Melatonin CRS; HSDB 7509; Melatobel (TN); TNP00300; Prestwick_312; N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide; Spectrum_000185; MELATONIN [DSC]; Guna-dermo (Salt/Mix); MELATONIN [MI]; MELATONIN [HSDB]; Prestwick0_000458; Prestwick1_000458; Prestwick2_000458; Prestwick3_000458; Spectrum2_001344; Spectrum3_001393; Spectrum4_000066; Spectrum5_001745; Lopac-M-5250; MELATONIN [VANDF]; M1105; Melatonin [EP monograph]; ChemDiv2_003916; MELATONIN [MART.]; M 5250; M-1200; Melatonin, >=99.5%; MELATONIN [USP-RS]; MELATONIN [WHO-DD]; Lopac0_000787; Oprea1_104553; Oprea1_814234; SCHEMBL19018; BSPBio_000536; BSPBio_003006; GTPL224; KBioGR_000591; KBioSS_000665; MELATONIN [EMA EPAR]; 5-22-12-00042 (Beilstein Handbook Reference); Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}; MLS000859594; MLS001055382; MLS001240204; BIDD:ER0618; DivK1c_000353; SPECTRUM1500690; Melatonin - Bio-X trade mark; N -Acetyl-5-methoxytryptamine; SPBio_001527; SPBio_002475; Melatonin (synth.) ultra-pure; MELATONIN [GREEN BOOK]; BDBM9019; BPBio1_000590; GTPL1357; orb1307851; orb3025362; Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}; SCHEMBL29349848; HMS501B15; KBio1_000353; KBio2_000665; KBio2_003233; KBio2_005801; KBio3_002226; Melatonin 1.0 mg/ml in Methanol; NINDS_000353; GLXC-25215; HMS1380B22; HMS1569K18; HMS1921E04; HMS2089F09; HMS2096K18; HMS2233D23; HMS3262M16; HMS3370J20; HMS3413P14; HMS3654A22; HMS3677P14; HMS3713K18; HMS3884M05; HMS5079K15; HMS6019H04; Melatonin (synth.) standard-grade; HY-B0075; MSK10126; Tox21_110195; Tox21_201527; Tox21_302926; Tox21_500787; CCG-38837; EBC-08635; HSCI1_000400; Melatonin for system suitability CRS; Melatonin, powder, >=98% (TLC); SBB003265; STK386880; AKOS000276269; Tox21_110195_1; CS-1769; DB01065; FA01297; KS-1454; LP00787; SDCCGMLS-0065812.P001; SDCCGMLS-0065812.P002; SDCCGSBI-0050765.P003; IDI1_000353; IDI1_002631; SMP2_000309; N-acetyl-5-methoxy-tryptamine Melatonine; NCGC00015680-01; NCGC00015680-02; NCGC00015680-03; NCGC00015680-04; NCGC00015680-05; NCGC00015680-06; NCGC00015680-07; NCGC00015680-08; NCGC00015680-09; NCGC00015680-10; NCGC00015680-12; NCGC00015680-13; NCGC00015680-14; NCGC00015680-15; NCGC00015680-16; NCGC00015680-18; NCGC00015680-28; NCGC00015680-34; NCGC00015680-35; NCGC00090727-01; NCGC00090727-02; NCGC00090727-03; NCGC00090727-04; NCGC00090727-05; NCGC00090727-06; NCGC00090727-07; NCGC00090727-08; NCGC00090727-09; NCGC00256404-01; NCGC00259077-01; NCGC00261472-01; AC-10019; BA164660; NCI60_004378; ST057260; SY051401; AB00053279; EU-0100787; NS00009598; SW196607-4; C01598; D08170; AB00053279-10; AB00053279_12; EN300-6486827; {N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide; L001261; N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-Acetamide; Q180912; SR-01000075559-1; SR-01000075559-6; SR-01000075559-7; SR-01000075559-8; {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide; BRD-K97530723-001-07-6; BRD-K97530723-001-11-8; BRD-K97530723-001-19-1; BRD-K97530723-001-20-9; N -[2-(5-Methoxy-1 H -indol-3-yl)ethyl]acetamide;; F1929-1777; Melatonin, British Pharmacopoeia (BP) Reference Standard; Z1191880499; 0E2B08C1-B325-45B1-8939-6F9081EFDFA4; Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI); Melatonin Working Standard (Secondary Reference Standard); Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI); Melatonin, United States Pharmacopeia (USP) Reference Standard; Melatonin, Pharmaceutical Secondary Standard; Certified Reference Material; N-Acetyl-5-methoxytryptamine; Circadin; N-(2-(5-methoxyindol-3-yl)ethyl)acetamide; N-Acetyl-5-methoxytryptamine; 3-(N-Acetyl-2-aminoethyl)-5-methoxyindole; Melatonin MicronizedSynonyms